* Working group on VEGF ‘-omics’ profiling in health (Sophie Visvikis-Siest, Sudha Seshadri, Marina Ciullo, Behrooz Alizadeh, Erik Ingelsson)
* Working group on VEGF ‘-omics’ profiling in diseases (Sudha Seshadri, Behrooz Alizadeh, Juan P Casas, Panos Deloukas, Georges Dagher, Janja Marc, Maurizio Simmaco, Sophie Visvikis-Siest)
* Working group on ‘-omics’ technologies (Panos Deloukas, Sudha Seshadri, Marina Ciullo, Behrooz Alizadeh, Sophie Visvikis-Siest)
* Working group on methodological aspects (Marina Ciullo, Behrooz Alizadeh, Panos Deloukas, Sudha Seshadri, Sophie Visvikis-Siest)
* Working Group on VEGF clinical implementation (John Lamont, Maurizio Simmaco, Sophie Visvikis-Siest)
* Working group on pharmagenomics (Sophie Visvikis-Siest, Juan P Casas)
* Working Group on Endothelins and Endothelial Factors (ESH) (Sophie Visvikis-Siest)
* Working group on VEGF basic research (cancer cell lines, animal models) (Janja Marc, Sophie Visvikis-Siest)
* Working group on VEGF and inflammation molecules (Behrooz Alizadeh, Sophie Visvikis-Siest)
* Working group on communication and scientific/educational meetings (Gerard Siest, Sophie Visvikis-Siest, Janja Marc, Maurizio Simmaco)
* Working group on raising awareness of populations (Maurizio Simmaco, Gerard Siest, Sophie Visvikis-Siest)
* Other working groups (to be defined)